Amanote Research
Register
Sign In
Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone and Naloxone at M, D, and K Opioid Receptors
doi 10.1021/jm061327z.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Effect of Linker Substitution on the Binding of Butorphan Univalent and Bivalent Ligands to Opioid Receptors
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Design, Synthesis and Biological Evaluation of Novel Bivalent Ligands Targeting Dopamine D2-Like Receptors and Μ Opioid Receptor
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Synthetic Route Towards Potential Bivalent Ligands Possessing Opioid and D2/D3 Pharmacophores
Journal of the Serbian Chemical Society
Chemistry
Extended-Release Naltrexone Opioid Treatment at Jail Reentry (XOR)
Contemporary Clinical Trials
Medicine
Pharmacology
Interactions of Ligands at Angiotensin II-Receptors and Imidazoline Receptors.
The Japanese Journal of Pharmacology
Synthesis, Binding Affinity, and Functional in Vitro Activity of 3-Benzylaminomorphinan and 3-Benzylaminomorphine Ligands at Opioid Receptors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Reply to Letters of M. Tanemura and E. M. Tory and D. K. Pickard
Journal of Applied Probability
Mathematics
Statistics
Uncertainty
Probability
Depot Naltrexone Decreases Rewarding Properties of Sugar in Patients With Opioid Dependence
Psychopharmacology
Pharmacology
Syntheses, Crystal Structures, and Photoluminescent Properties of a Series of M(II) Coordination Polymers Containing M-X2-M Bridges: From 1-D Chains to 2-D Networks
